Back to Search Start Over

A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials.

Authors :
Sill, Michael W
Rubinstein, Larry
Litwin, Samuel
Yothers, Greg
Source :
Clinical Trials; Aug2012, Vol. 9 Issue 4, p385-395, 11p, 5 Charts, 3 Graphs
Publication Year :
2012

Details

Language :
English
ISSN :
17407745
Volume :
9
Issue :
4
Database :
Complementary Index
Journal :
Clinical Trials
Publication Type :
Academic Journal
Accession number :
79442584
Full Text :
https://doi.org/10.1177/1740774512450101